[PSA] research peptides are not what most of this community thinks it is
Putting this at the top of the board where it belongs: research peptides are not what most of this community thinks it is.
Net peptide content accounts for counterion, water and residual solvent. On some of these compounds the gap between purity and net content is substantial and entirely honest.
Stocked lines and made-to-order lines have different lead times and different storage histories. Both are ordinary; the difference is worth confirming before you commit.
Storage guidance that names a temperature, a state and a duration reflects actual stability work. Generic guidance usually reflects a template.
Research-use-only material is not approved for human use and nothing here should be read as a recommendation to use it.
best — the order this archive was captured in
For any compound with a thin testing history, identity is the first question. Mass spectrometry against a theoretical mass answers it; an area-percent purity figure does not.
For any compound with a thin testing history, identity is the first question.
tuva_iyer is right that a purity figure without a method is not comparable to one with a method.
Bought small on anything without a testing history here. That rule has never once cost me anything.
Independent result added to the log — there are very few on that compound.
Confirmed the lead time in writing before ordering a made-to-order line. It was longer than the site suggested and entirely reasonable once explained.
Confirmed the lead time in writing before ordering a made-to-order line.
Agreed — and the naming problem is worse than most people here realise.
Naming in this space is inconsistent. Several widely used names map to more than one molecule, so a catalogue number and a sequence beat a common name every time.
the same name covers several different molecules in this space
This. Asking what reference standard was used separates a real analytical claim from a plausible-looking one.
Research-use-only material is not approved for human use. In this catalogue that covers essentially everything, which is why the board discusses material and analytics rather than outcomes.
What lead time were you quoted for that line?
handling and storage vary enormously across this catalogue
What lead time were you quoted for that line?
This is the rule for anything unusual. Identity before anything else.
research-use-only material is not approved for human use
lead times on unusual lines are the thing to confirm up front
identity before purity, every time, for anything unusual
Push back: handling advice from one compound does not transfer to another just because both are peptides.
lead times on unusual lines are the thing to confirm up front
Disagreeing with this bit: handling for one compound does not transfer to another by default.
the less-tested the compound, the more the identity test matters
Purity methods differ by compound class. A gradient and wavelength developed for one peptide will not necessarily resolve the relevant impurities of another.
- 1This. Asking what reference standard was used separates a real analytical…13 comments in this branch · started by u/erez_yilmaz